[1] F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, and A. Jemal, “Global
cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for
36 cancers in 185 countries,” CA: A Cancer Journal for Clinicians, vol. 68, no. 6,
pp. 394–424, 2018.
[2] C. L. Vogel, M. A. Cobleigh, D. Tripathy, J. C. Gutheil, L. N. Harris, L. Fehrenbacher,
D. J. Slamon, M. Murphy, W. F. Novotny, M. Burchmore, S. Shak, S. J.
Stewart, and M. Press, “Efficacy and safety of trastuzumab as a single agent in firstline
treatment of HER2-overexpressing metastatic breast cancer,” J. Clin. Oncol.,
vol. 20, no. 3, pp. 719–726, 2002.
[3] M. J. Piccart-Gebhart, M. Procter, B. Leyland-Jones, A. Goldhirsch, M. Untch,
I. Smith, L. Gianni, J. Baselga, R. Bell, C. Jackisch, et al., “Trastuzumab after
adjuvant chemotherapy in her2-positive breast cancer,” New England Journal of
Medicine, vol. 353, no. 16, pp. 1659–1672, 2005.
[4] B. Kaufman, M. Trudeau, A. Awada, K. Blackwell, T. Bachelot, V. Salazar, M. De-
Silvio, R. Westlund, T. Zaks, N. Spector, and S. Johnston, “Lapatinib monotherapy
in patients with HER2-overexpressing relapsed or refractory inflammatory breast
cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a
phase II study,” Lancet Oncol., vol. 10, no. 6, pp. 581–588, 2009.
[5] A. Emde, W. J. Köstler, Y. Yarden, and Association of Radiotherapy and Oncology
of the Mediterranean arEa (AROME), “Therapeutic strategies and mechanisms of
tumorigenesis of HER2-overexpressing breast cancer,” Crit. Rev. Oncol. Hematol.,
vol. 84 Suppl 1, pp. e49–57, 2012.
[6] T. Hilal and E. H. Romond, “ERBB2 (HER2) testing in breast cancer,” JAMA,
vol. 315, no. 12, pp. 1280–1281, 2016.
[7] S. Kunte, J. Abraham, and A. J. Montero, “Novel her2–targeted therapies for her2–
positive metastatic breast cancer,” Cancer, vol. 126, no. 19, pp. 4278–4288, 2020.
[8] M. F. Press, J. A. Seoane, C. Curtis, E. Quinaux, R. Guzman, G. Sauter, W. Eiermann,
J. R. Mackey, N. Robert, T. Pienkowski, et al., “Assessment of erbb2/her2 status in
her2-equivocal breast cancers by fish and 2013/2014 asco-cap guidelines,” JAMA
oncology, vol. 5, no. 3, pp. 366–375, 2019.
[9] S. Agersborg, C. Mixon, T. Nguyen, S. Aithal, S. Sudarsanam, F. Blocker, L. Weiss,
R. Gasparini, S. Jiang, W. Chen, G. Hess, and M. Albitar, “Immunohistochemistry
and alternative FISH testing in breast cancer with HER2 equivocal amplification,”
Breast Cancer Res. Treat., vol. 170, no. 2, pp. 321–328, 2018.
[10] M. Edelweiss, A. P. M. Sebastiao, H. Oen, M. Kracun, R. Serrette, and D. S. Ross,
“Her2 assessment by bright-field dual in situ hybridization in cell blocks of recurrent
and metastatic breast carcinoma,” Cancer cytopathology, vol. 127, no. 11, pp. 684–
690, 2019.
[11] M. Troxell, R. K. Sibley, R. B. West, G. R. Bean, and K. H. Allison, “HER2 dual
in situ hybridization: Correlations and cautions,” Arch. Pathol. Lab. Med., vol. 144,
no. 12, pp. 1525–1534, 2020.
[12] Z.-H. Liu, K. Wang, D.-Y. Lin, J. Xu, J. Chen, X.-Y. Long, Y. Ge, X.-L. Luo, K.-P.
Zhang, Y.-H. Liu, et al., “Impact of the updated 2018 asco/cap guidelines on her2
fish testing in invasive breast cancer: a retrospective study of her2 fish results of
2233 cases,” Breast cancer research and treatment, vol. 175, no. 1, pp. 51–57, 2019.
[13] D. J. Slamon, B. Leyland-Jones, S. Shak, H. Fuchs, V. Paton, A. Bajamonde,
T. Fleming, W. Eiermann, J. Wolter, M. Pegram, et al., “Use of chemotherapy plus
a monoclonal antibody against her2 for metastatic breast cancer that overexpresses
her2,” New England journal of medicine, vol. 344, no. 11, pp. 783–792, 2001.
[14] H. J. Burstein, L. N. Harris, P. K. Marcom, R. Lambert-Falls, K. Havlin, B. Overmoyer,
R. J. Friedlander Jr, J. Gargiulo, R. Strenger, C. L. Vogel, et al., “Trastuzumab
and vinorelbine as first-line therapy for her2-overexpressing metastatic breast cancer:
multicenter phase ii trial with clinical outcomes, analysis of serum tumor markers
as predictive factors, and cardiac surveillance algorithm,” Journal of clinical
oncology, vol. 21, no. 15, pp. 2889–2895, 2003.
[15] K.-H. Yu, A. L. Beam, and I. S. Kohane, “Artificial intelligence in healthcare,” Nature
biomedical engineering, vol. 2, no. 10, pp. 719–731, 2018.
[16] F. Zakrzewski, W. de Back, M. Weigert, T. Wenke, S. Zeugner, R. Mantey, C. Sperling,
K. Friedrich, I. Roeder, D. Aust, et al., “Automated detection of the her2 gene
amplification status in fluorescence in situ hybridization images for the diagnostics
of cancer tissues,” Scientific reports, vol. 9, no. 1, pp. 1–12, 2019.
[17] K. Bera, K. A. Schalper, D. L. Rimm, V. Velcheti, and A. Madabhushi, “Artificial
intelligence in digital pathology—new tools for diagnosis and precision oncology,”
Nature reviews Clinical oncology, vol. 16, no. 11, pp. 703–715, 2019.
[18] Y. LeCun, Y. Bengio, and G. Hinton, “Deep learning,” nature, vol. 521, no. 7553,
pp. 436–444, 2015.
[19] E. Kats, J. Goldberger, and H. Greenspan, “A soft staple algorithm combined with
anatomical knowledge,” in International Conference on Medical Image Computing
and Computer-Assisted Intervention, pp. 510–517, Springer, 2019.
[20] C. Gros, A. Lemay, and J. Cohen-Adad, “Softseg: Advantages of soft versus binary
training for image segmentation,” Medical Image Analysis, vol. 71, p. 102038, 2021.
[21] R. Müller, S. Kornblith, and G. Hinton, “When does label smoothing help?,” in Proceedings
of the 33rd International Conference on Neural Information Processing
Systems, Curran Associates Inc., 2019.
[22] O. Ronneberger, P. Fischer, and T. Brox, “U-net: Convolutional networks for
biomedical image segmentation,” in Medical Image Computing and Computer-
Assisted Intervention – MICCAI 2015 (N. Navab, J. Hornegger, W. M. Wells, and
A. F. Frangi, eds.), (Cham), pp. 234–241, Springer International Publishing, 2015.
[23] C.-B. Zhang, P.-T. Jiang, Q. Hou, Y. Wei, Q. Han, Z. Li, and M.-M. Cheng, “Delving
deep into label smoothing,” IEEE Transactions on Image Processing, vol. 30,
pp. 5984–5996, 2021.
[24] A. Van Engelen, W. Niessen, S. Klein, H. Verhagen, H. Groen, J. Wentzel, A. Lugt,
and M. de Bruijne, “Supervised in-vivo plaque characterization incorporating class
label uncertainty,” 2012.
[25] T. T. de Weert, M. Ouhlous, E. Meijering, P. E. Zondervan, J. M. Hendriks, M. R.
van Sambeek, D. W. Dippel, and A. van der Lugt, “In vivo characterization and
quantification of atherosclerotic carotid plaque components with multidetector computed tomography and histopathological correlation,” Arteriosclerosis, thrombosis,
and vascular biology, vol. 26, no. 10, pp. 2366–2372, 2006.
[26] L. Qi, L. Wang, J. Huo, Y. Shi, and Y. Gao, “Progressive cross-camera soft-label
learning for semi-supervised person re-identification,” IEEE Transactions on Circuits
and Systems for Video Technology, vol. 30, no. 9, pp. 2815–2829, 2020.
[27] S. Warfield, K. Zou, and W. Wells, “Simultaneous truth and performance level estimation
(staple): an algorithm for the validation of image segmentation,” IEEE Transactions
on Medical Imaging, vol. 23, no. 7, pp. 903–921, 2004.
[28] H. Li, D. Wei, S. Cao, K. Ma, L. Wang, and Y. Zheng, “Superpixel-guided label
softening for medical image segmentation,” 2020.
[29] H. H. Pham, T. T. Le, D. Q. Tran, D. T. Ngo, and H. Q. Nguyen, “Interpreting chest xrays
via cnns that exploit hierarchical disease dependencies and uncertainty labels,”
Neurocomputing, vol. 437, pp. 186–194, 2021.
[30] H.-H. Zhao, P. L. Rosin, Y.-K. Lai, and Y.-N. Wang, “Automatic semantic style transfer
using deep convolutional neural networks and soft masks,” The Visual Computer,
vol. 36, no. 7, pp. 1307–1324, 2020.
[31] J. Chorowski and N. Jaitly, “Towards better decoding and language model integration
in sequence to sequence models,” arXiv preprint arXiv:1612.02695, 2016.
[32] A. Vaswani, N. Shazeer, N. Parmar, J. Uszkoreit, L. Jones, A. N. Gomez, Ł. Kaiser,
and I. Polosukhin, “Attention is all you need,” Advances in neural information processing
systems, vol. 30, 2017.
[33] H. J.Kuijf and E. Bennink, “Grand challenge on mr brain segmentation at miccai
2018,”
[34] A. Krizhevsky, V. Nair, and G. Hinton, “Cifar-100 (canadian institute for advanced
research),”
[35] Y.-J. Lin, T.-K. Chao, M.-A. Khalil, Y.-C. Lee, D.-Z. Hong, J.-J. Wu, and C.-W.
Wang, “Deep learning fast screening approach on cytological whole slides for thyroid
cancer diagnosis,” Cancers, vol. 13, no. 15, p. 3891, 2021.
[36] E. Shelhamer, J. Long, and T. Darrell, “Fully convolutional networks for semantic
segmentation,” IEEE transactions on pattern analysis and machine intelligence,
vol. 39, no. 4, pp. 640–651, 2017.
[37] X. Wang, R. Zhang, T. Kong, L. Li, and C. Shen, “Solov2: Dynamic and fast instance
segmentation,” Advances in Neural information processing systems, vol. 33,
pp. 17721–17732, 2020.
[38] L.-C. Chen, Y. Zhu, G. Papandreou, F. Schroff, and H. Adam, “Encoder-decoder with
atrous separable convolution for semantic image segmentation,” in Proceedings of
the European conference on computer vision (ECCV), pp. 801–818, 2018.
[39] C.-W. Wang, Y.-A. Liou, Y.-J. Lin, C.-C. Chang, P.-H. Chu, Y.-C. Lee, C.-H. Wang,
and T.-K. Chao, “Artificial intelligence-assisted fast screening cervical high grade
squamous intraepithelial lesion and squamous cell carcinoma diagnosis and treatment
planning,” Scientific Reports, vol. 11, no. 1, pp. 1–14, 2021.
[40] C.-W. Wang, M.-A. Khalil, Y.-J. Lin, Y.-C. Lee, T.-W. Huang, and T.-K. Chao,
“Deep learning using endobronchial-ultrasound-guided transbronchial needle aspiration
image to improve the overall diagnostic yield of sampling mediastinal lymphadenopathy,”
Diagnostics, vol. 12, p. 2234, 2022.
[41] M.-A. Khalil, Y.-C. Lee, H.-C. Lien, Y.-M. Jeng, and C.-W. Wang, “Fast segmentation
of metastatic foci in h&e whole-slide images for breast cancer diagnosis,”
Diagnostics, vol. 12, no. 4, p. 990, 2022.
[42] C.-W. Wang, Y.-C. Lee, C.-C. Chang, Y.-J. Lin, Y.-A. Liou, P.-C. Hsu, C.-C. Chang,
A.-K.-O. Sai, C.-H. Wang, and T.-K. Chao, “A weakly supervised deep learning
method for guiding ovarian cancer treatment and identifying an effective biomarker,”
Cancers, vol. 14, no. 7, p. 1651, 2022.
[43] C.-W. Wang, C.-C. Chang, Y.-C. Lee, Y.-J. Lin, S.-C. Lo, P.-C. Hsu, Y.-A. Liou,
C.-H. Wang, and T.-K. Chao, “Weakly supervised deep learning for prediction of
treatment effectiveness on ovarian cancer from histopathology images,” Computerized
Medical Imaging and Graphics, vol. 99, p. 102093, 2022.
[44] J. Shen, T. Li, C. Hu, H. He, D. Jiang, and J. Liu, “An augmented cell segmentation in
fluorescent in situ hybridization images,” in 2019 41st Annual International Conference
of the IEEE Engineering in Medicine and Biology Society (EMBC), pp. 6306–
6309, IEEE, 2019.
[45] J. Shen, T. Li, C. Hu, H. He, and J. Liu, “Automatic cell segmentation using
mini-u-net on fluorescence in situ hybridization images,” in Medical Imaging 2019:
Computer-Aided Diagnosis, vol. 10950, pp. 721–727, SPIE, 2019.
[46] E. Upschulte, S. Harmeling, K. Amunts, and T. Dickscheid, “Contour proposal networks for biomedical instance segmentation,” Medical Image Analysis, p. 102371,
2022.
[47] V. Ljosa, K. L. Sokolnicki, and A. E. Carpenter, “Annotated high-throughput microscopy image sets for validation.,” Nature methods, vol. 9, no. 7, pp. 637–637,
2012.
[48] L. Ke, Y.-W. Tai, and C.-K. Tang, “Deep occlusion-aware instance segmentation with
overlapping bilayers,” in Proceedings of the IEEE/CVF Conference on Computer
Vision and Pattern Recognition (CVPR), pp. 4019–4028, 2021.
[49] T.-Y. Lin, M. Maire, S. Belongie, J. Hays, P. Perona, D. Ramanan, P. Dollár, and C. L. Zitnick, “Microsoft coco: Common objects in context,” in European conference on
computer vision, pp. 740–755, Springer, 2014.
[50] M. Cordts, M. Omran, S. Ramos, T. Rehfeld, M. Enzweiler, R. Benenson, U. Franke,
S. Roth, and B. Schiele, “The cityscapes dataset for semantic urban scene understanding,” in Proceedings of the IEEE conference on computer vision and pattern
recognition, pp. 3213–3223, 2016.
[51] T. Falk, D. Mai, R. Bensch, Ö. Çiçek, A. Abdulkadir, Y. Marrakchi, A. Böhm,
J. Deubner, Z. Jäckel, K. Seiwald, et al., “U-net: deep learning for cell counting,
detection, and morphometry,” Nature methods, vol. 16, no. 1, pp. 67–70, 2019.
[52] C. Szegedy, S. Ioffe, V. Vanhoucke, and A. A. Alemi, “Inception-v4, inception-resnet and the impact of residual connections on learning,” in Thirty-first AAAI conference
on artificial intelligence, 2017.
[53] K. He, X. Zhang, S. Ren, and J. Sun, “Deep residual learning for image recognition,” in Proceedings of the IEEE conference on computer vision and pattern recognition,
pp. 770–778, 2016.
[54] V. Badrinarayanan, A. Kendall, and R. Cipolla, “Segnet: A deep convolutional
encoder-decoder architecture for image segmentation,” IEEE transactions on pattern
analysis and machine intelligence, vol. 39, no. 12, pp. 2481–2495, 2017.
[55] F. Jubayer, J. A. Soeb, A. N. Mojumder, M. K. Paul, P. Barua, S. Kayshar, S. S. Akter, M. Rahman, and A. Islam, “Detection of mold on the food surface using yolov5,”
Current Research in Food Science, vol. 4, pp. 724–728, 2021.
[56] A. G. Howard, M. Zhu, B. Chen, D. Kalenichenko, W. Wang, T. Weyand, M. Andreetto,
and H. Adam, “Mobilenets: Efficient convolutional neural networks for mobile
vision applications,” arXiv preprint arXiv:1704.04861, 2017.
[57] F. Chollet, “Xception: Deep learning with depthwise separable convolutions,” in
Proceedings of the IEEE conference on computer vision and pattern recognition,
pp. 1251–1258, 2017.
[58] S. Liu and W. Deng, “Very deep convolutional neural network based image classification
using small training sample size,” in 2015 3rd IAPR Asian Conference on
Pattern Recognition (ACPR), pp. 730–734, 2015.